Nutritional status, clinical Features and lifestyle of Twins Discordant for Parkinson’s Disease
Objective: To characterize nutritional status (body weight, body mass index [BMI]), dietary habits, and lifestyle factors (smoking) of twins discordant for Parkinson’s disease (PD). Background:…The enteric footprint of de novo parkinson’s disease cohort: constipation, inflammation, and nulisa biomarker profiling.
Objective: This study aimed to analyze constipation symptoms and blood, CSF and fecal biomarkers, including a High-plex Profiling of Inflammatory Proteins (NULISA) in a de novo PD cohort. Background: Parkinson’s disease…A Tiered Fecal Biomarker Approach to Identify Gut–Brain Axis Phenotypes in Young-Onset Parkinsonism in a Clinical Setting with Limited Resources
Objective: To explore the feasibility of a tiered fecal biomarker testing approach to identify potential gut–brain axis phenotypes in patients with young-onset parkinsonism in a…Genetic Predictors in Dystonia: A Phenotypic Analysis.
Objective: To identify clinical predictors of genetic positivity in dystonia and to develop a phenotype-based predictive score to guide genetic testing. Background: Dystonia is a…Engage in Healthy Eating: A Community-Guided Approach to Culturally Sensitive Nutrition Support for People with Parkinson’s Disease (PD)
Objective: To co-develop a culturally affirming, family-centered Healthy Eating Program with community members for managing PD symptoms and achieving personal wellness goals. Background: Growing evidence…A Pragmatic Phenotype-Guided Algorithm for Constipation in Parkinson’s Disease
Objective: Evaluate the effect of a structured Mediterranean-style high fiber diet as the cornerstone of treatment with additional therapies layered when needed (FIBER-MED), using a…Nutrition and Dietary Assessment as a Wellness Factor in Parkinson’s Disease and Related Disorders
Objective: To characterize nutrition and food related concerns identified during supportive care visits for individuals with Parkinson’s disease (PD) and related disorders. Background: Individuals with…Hyperbaric Oxygen Therapy for Parkinson’s disease via modulation of gut microbiota
Objective: To investigate the effect of hyperbaric oxygen therapy (HBOT) on gut microbiota in a preclinical model of PD. Background: Humans have coevolved with complex…Advancements in Microbiome Research: Total Microbial Load, Differential Absolute Abundance, and Correlations with Immune Transcriptomics
Objective: Quantify total microbial load in the gut microbiome of people with Parkinson’s disease (PD) and compare the absolute abundance of bacterial taxa between PD…Gastrointestinal Dysfunction and Levodopa Therapeutic Response in Parkinson’s Disease: A Brazilian Cross-sectional Study
Objective: To investigate the relation between constipation and the onset time of levodopa therapeutic effect in Parkinson's disease (PD). Background: Levodopa therapeutic response depends on…
- 1
- 2
- 3
- …
- 9
- Next Page »
